Abstract
Background
Our previous studies suggest that the training history of an investigator, termed “medical academic genealogy”, influences the outcomes of that investigator’s research. Here, we use meta-analysis and quantitative statistical modeling to determine whether such effects contribute to systematic bias in published conclusions.
Methods
A total of 108 articles were identified through a comprehensive search of the high-grade glioma (HGG) surgical resection literature. Analysis was performed on the 70 articles with sufficient data for meta-analysis. Pooled estimates were generated for key academic genealogies. Monte Carlo simulations were performed to determine whether the effects attributed to genealogy alone can arise due to chance alone.
Results
Meta-analysis of the HGG literature without consideration for academic medical genealogy revealed that gross total resection (GTR) was associated with a significant decrease in the odds ratio (OR) for the hazard of death after surgery for both anaplastic astrocytoma (AA) and glioblastoma (AA: log [OR] = − 0.04, 95% CI [− 0.07 to − 0.01]; glioblastoma log [OR] = − 0.36, 95% CI [− 0.44 to − 0.29]). For the glioblastoma literature, meta-analysis of articles contributed by members of a genealogy consisting of mostly radiation oncologists revealed no reduction in the hazard of death after GTR [log [OR] = − 0.16, 95% CI [− 0.41 to 0.09]. In contrast, meta-analysis of published articles contributed by members of a genealogy consisting of mostly neurosurgeons revealed that GTR was associated with a significant reduction in the hazard of death [log [OR] = − 0.29, 95% CI [− 0.40 to 0.18]. Monte Carlo simulation revealed that the observed discrepancy between the articles contributed by the members of these two genealogies was unlikely to arise by chance alone (p < 0.006).
Conclusions
Meta-analysis of articles contributed by authors belonging to the different medical academic genealogies yielded distinct and contradictory pooled point-estimates, suggesting that genealogy contributes to systematic bias in the published literature.
Similar content being viewed by others
References
Academic Genealogy Wiki (2014) Available at: http://phdtree.org/. Accessed 7 Oct 2015
Barr AH Jr (1936) Cubism and abstract art. Belknap Press, Cambridge
Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT (2012) Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg 117(6):1032–1038. https://doi.org/10.3171/2012.9.JNS12504
Butowski N, Lamborn KR, Berger MS, Prados MD, Chang SM (2007) Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme. J Neuro-Oncol 85(1):87–94
Carico C, Nuño M, Mukherjee D, Elramsisy A, Dantis J, Hu J, Rudnick J, Yu JS, Black KL, Bannykh SI, Patil CG (2012) Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era. PLoS One 7(3):e33684. https://doi.org/10.1371/journal.pone.0033684
Carley K (2003) Dynamic network analysis. In: Breiger R, Carley K, Pattison P (eds) Dynamic social network modeling and analysis: workshop summary and papers. National Academies Press, Washington, DC, pp 133–145
Chaichana K, Parker S, Olivi A, Quiñones-Hinojosa A (2010) A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. J Neurosurg 112(5):997–1004. https://doi.org/10.3171/2009.9.JNS09805
Chaichana KL, Martinez-Gutierrez JC, De la Garza-Ramos R, Weingart JD, Olivi A, Gallia GL, Lim M, Brem H, Quinones-Hinojosa A (2013) Factors associated with survival for patients with glioblastoma with poor pre-operative functional status. J Clin Neurosci 20(6):818–823. https://doi.org/10.1016/j.jocn.2012.07.016
Chaichana KL, Cabrera-Aldana EE, Jusue-Torres I, Wijesekera O, Olivi A, Rahman M, Quinones-Hinojosa A (2014) When gross total resection of a glioblastoma is possible, how much resection should be achieved? World Neurosurg 82(1–2):e257–e265. https://doi.org/10.1016/j.wneu.2014.01.019
Chaichana KL, Jusue-Torres I, Navarro-Ramirez R, Raza SM, Pascual-Gallego M, Ibrahim A, Hernandez-Hermann M, Gomez L, Ye X, Weingart JD, Olivi A, Blakeley J, Gallia GL, Lim M, Brem H, Quinones-Hinojosa A (2014) Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro-Oncology 16(1):113–122. https://doi.org/10.1093/neuonc/not137
Fogh SE, Andrews DW, Glass J, Curran W, Glass C, Champ C, Evans JJ, Hyslop T, Pequignot E, Downes B, Comber E, Maltenfort M, Dicker AP, Werner-Wasik M (2010) Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol 28(18):3048–3053. https://doi.org/10.1200/JCO.2009.25.6941
Gonda DD, Warnke P, Sanai N, Taich Z, Kasper EM, Chen CC (2013) The value of extended glioblastoma resection: Insights from randomized controlled trials. Surg Neurol Int 4. India. https://doi.org/10.4103/2152-7806.117173
Hirshman BR, Jones LA, Tang JA, Proudfoot JA, Carley KM, Carter BS, Chen CC (2016) 'Journal Bias' in peer-reviewed literature: an analysis of the surgical high-grade glioma literature. J Neurol Neurosurg Psychiatry 87(11):1248–1250. https://doi.org/10.1136/jnnp-2015-312998
Hirshman BR, Tang JA, Jones LA, Proudfoot JA, Carley KM, Marshall L, Carter BS, Chen CC (2016) Impact of medical academic genealogy on publication patterns: an analysis of the literature for surgical resection in brain tumor patients. Ann Neurol 79:169–177
Jackson A (2007) A labor of love: the mathematics genealogy project. North Am Math Soc 54:1002–1003
Kaur G, Bloch O, Jian BJ, Kaur R, Sughrue ME, Aghi MK, McDermott MW, Berger MS, Chang SM, Parsa AT (2011) A critical evaluation of cystic features in primary glioblastoma as a prognostic factor for survival. J Neurosurg 115(4):754–759. https://doi.org/10.3171/2011.5.JNS11128
Keles GE, Anderson B, Berger MS (1999) The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 52(4):371–379
Kolker JD, Halpern HJ, Krishnasamy S, Brown F, Dohrmann G, Ferguson L, Hekmatpanah J, Mullan J, Wollman R, Blough R et al (1990) "instant-mix" whole brain photon with neutron boost radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 19(2):409–414
Kowalczuk A, Macdonald RL, Amidei C, Dohrmann G 3rd, Erickson RK, Hekmatpanah J, Krauss S, Krishnasamy S, Masters G, Mullan SF, Mundt AJ, Sweeney P, Vokes EE, Weir BK, Wollman RL (1997) Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 41(5):1028–1036
Kreth FW, Warnke PC, Scheremet R, Ostertag CB (1993) Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78:762–766
Krishnasamy S, Vokes EE, Dohrmann GJ, Mick R, Garcia JC, Kolker JD, Wollmann RL, Hekmatpanah J, Weichselbaum RR (1995) Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme. Cancer Investig 13(5):453–459
Mathematics Genealogy Project (2014) Available at: http://genealogy.math.ndsu.nodak.edu/. Accessed 7 Oct 2015
McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, Weingart JD, Brem H, Quiñones-Hinojosa AR (2009) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110(1):156–162. https://doi.org/10.3171/2008.4.17536
Oppenlander ME, Wolf AB, Snyder LA, Bina R, Wilson JR, Coons SW, Ashby LS, Brachman D, Nakaji P, Porter RW, Smith KA, Spetzler RF, Sanai N (2014) An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity. J Neurosurg 120(4):846–853. https://doi.org/10.3171/2013.12.JNS13184
Patil CG, Yi A, Elramsisy A, Hu J, Mukherjee D, Irvin DK, Yu JS, Bannykh SI, Black KL, Nuño M (2012) Prognosis of patients with multifocal glioblastoma: a case-control study. J Neurosurg 117(4):705–711. https://doi.org/10.3171/2012.7.JNS12147
Patil CG, Nuño M, Elramsisy A, Mukherjee D, Carico C, Dantis J, Hu J, Yu JS, Fan X, Black KL, Bannykh SI (2013) High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide era. Neuro-Oncology 15(1):104–111. https://doi.org/10.1093/neuonc/nos272
Piano Genealogy Database (2015) http://www.pianogenealogy.com.au/. Accessed 5 May 2015
R Core Team (2014) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. http://www.R-project.org/. Accessed May 2018
Ramakrishna R, Barber J, Kennedy G, Rizvi A, Goodkin R, Winn RH, Ojemann GA, Berger MS, Spence AM, Rostomily RC (2010) Imaging features of invasion and preoperative and postoperative tumor burden in previously untreated glioblastoma: correlation with survival. Surg Neurol Int 1. https://doi.org/10.4103/2152-7806.68337
Robert CP, Elvira V, Tawn N, Wu C (2018) Accelerating MCMC algorithms. Wiley Interdiscip Rev Comput Stat 10(5):e1435. https://doi.org/10.1002/wics.1435
Roberts PS, Nuño M, Sherman D, Asher A, Wertheimer J, Riggs RV, Patil CG (2014) The impact of inpatient rehabilitation on function and survival of newly diagnosed patients with glioblastoma. PM R 6(6):514–521. https://doi.org/10.1016/j.pmrj.2013.12.007
Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115(1):3–8. https://doi.org/10.3171/2011.2.JNS10998
Sarmiento JM, Nuño M, Ortega A, Mukherjee D, Fan X, Black KL, Patil CG (2014) Cystic glioblastoma: an evaluation of IDH1 status and prognosis. Neurosurgery 74(1):71–75. https://doi.org/10.1227/NEU.0000000000000200
Scharp K (2014) History of Western Philosophy
Scott J (2000) Social network analysis: a handbook, 2nd edn. Sage, London
Showalter TN, Andrel J, Andrews DW, Curran WJ Jr, Daskalakis C, Werner-Wasik M (2007) Multifocal glioblastoma multiforme: prognostic factors and patterns of progression. Int J Radiat Oncol Biol Phys 69(3):820–824
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
The Academic Family Tree (2014) Available at: http://academictree.org/. Accessed 7 Oct 2015
Wallner KE, Galicich JH, Malkin MG, Arbit E, Krol G, Rosenblum MK (1989) Inability of computed tomography appearance of recurrent malignant astrocytoma to predict survival following reoperation. J Clin Oncol 7(10):1492–1496
Wasserman S, Faust K (1994) Social network analysis. Cambridge University Press, Cambridge
Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC et al (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-Oncology 5:79–88
Woodworth GF, Garzon-Muvdi T, Ye X, Blakeley JO, Weingart JD, Burger PC (2013) Histopathological correlates with survival in reoperated glioblastomas. J Neuro-Oncol 113(3):485–493. https://doi.org/10.1007/s11060-013-1141-3
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed consent
For this type of study, formal consent is not required.
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
A formal approval by the institutional ethics committee was not required for this study since all articles, journals, and author data were collected from publicly available sources.
Animal experiments
Ethical approval: This article does not contain any studies with animals performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Neurosurgery general
Rights and permissions
About this article
Cite this article
Hirshman, B.R., Alattar, A.A., Dhawan, S. et al. Association between medical academic genealogy and publication outcome: impact of unconscious bias on scientific objectivity. Acta Neurochir 161, 205–211 (2019). https://doi.org/10.1007/s00701-019-03804-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-019-03804-9